NO901231L - Fremgangsmaate for fremstilling av et farmasoeytisk preparat - Google Patents

Fremgangsmaate for fremstilling av et farmasoeytisk preparat

Info

Publication number
NO901231L
NO901231L NO90901231A NO901231A NO901231L NO 901231 L NO901231 L NO 901231L NO 90901231 A NO90901231 A NO 90901231A NO 901231 A NO901231 A NO 901231A NO 901231 L NO901231 L NO 901231L
Authority
NO
Norway
Prior art keywords
preparing
procedure
pharmaceutical preparation
patients
ring
Prior art date
Application number
NO90901231A
Other languages
English (en)
Other versions
NO901231D0 (no
Inventor
Barry Anthony Murrer
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Publication of NO901231D0 publication Critical patent/NO901231D0/no
Publication of NO901231L publication Critical patent/NO901231L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Forbindelser som er cykliske aminer med en 12 til 20-leddet ring og med fra 3 til 5 aminogrupper i ringen, og deres komplekser og beskyttede former er aktive mot retroviruser og kan anvendes i farmasøytiske preparater for behandling av smittede pasienter eller utsatte pasienter.
NO90901231A 1989-03-17 1990-03-16 Fremgangsmaate for fremstilling av et farmasoeytisk preparat NO901231L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898906190A GB8906190D0 (en) 1989-03-17 1989-03-17 Improvements in chemical compounds

Publications (2)

Publication Number Publication Date
NO901231D0 NO901231D0 (no) 1990-03-16
NO901231L true NO901231L (no) 1990-09-18

Family

ID=10653540

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90901231A NO901231L (no) 1989-03-17 1990-03-16 Fremgangsmaate for fremstilling av et farmasoeytisk preparat

Country Status (16)

Country Link
EP (1) EP0392666B1 (no)
JP (1) JPH02279624A (no)
KR (1) KR900013948A (no)
AT (1) ATE108654T1 (no)
AU (1) AU628492B2 (no)
CA (1) CA2012150A1 (no)
DE (1) DE69010736T2 (no)
ES (1) ES2056374T3 (no)
GB (1) GB8906190D0 (no)
HU (1) HU206262B (no)
IE (1) IE900936L (no)
IL (1) IL93728A (no)
NO (1) NO901231L (no)
NZ (1) NZ232930A (no)
PT (1) PT93477A (no)
ZA (1) ZA901992B (no)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888877A (en) * 1969-06-11 1975-06-10 Schering Corp Macrocyclic compounds and complexes thereof
US4156683A (en) * 1973-03-26 1979-05-29 Schering Corporation Complexes of macrocyclic compounds
WO1987002246A1 (en) * 1985-10-21 1987-04-23 William Sergio Method for reducing the risk or probability of infection from the aids virus (htlv-iii/lav/arv)

Also Published As

Publication number Publication date
PT93477A (pt) 1990-11-07
CA2012150A1 (en) 1990-09-17
IL93728A0 (en) 1990-12-23
HU206262B (en) 1992-10-28
EP0392666A2 (en) 1990-10-17
NO901231D0 (no) 1990-03-16
DE69010736T2 (de) 1994-11-24
EP0392666B1 (en) 1994-07-20
IL93728A (en) 1994-11-28
AU5141190A (en) 1990-09-20
IE900936L (en) 1990-09-17
ATE108654T1 (de) 1994-08-15
AU628492B2 (en) 1992-09-17
HUT54300A (en) 1991-02-28
KR900013948A (ko) 1990-10-22
EP0392666A3 (en) 1993-03-03
JPH02279624A (ja) 1990-11-15
DE69010736D1 (de) 1994-08-25
ES2056374T3 (es) 1994-10-01
GB8906190D0 (en) 1989-05-04
NZ232930A (en) 1992-05-26
ZA901992B (en) 1990-12-28
HU901594D0 (en) 1990-06-28

Similar Documents

Publication Publication Date Title
ATE209908T1 (de) RADIKALFÄNGER (ßSPIN TRAPSß) ZUR BEHANDLUNG VON MIT OXIDATION VON LIPIDEN UND PROTEINEN VERBUNDENEN ERKRANKUNGEN
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
DE69230500D1 (de) Pharmazeutische Dipeptid Zusammensetzungen und Verwendungsmethoden.
ES554967A0 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
ATE2667T1 (de) Antidepressiv wirkende derivate des trans-4phenyl-1,2,3,4-tetrahydro-1-naphthalin-amins und pharmazeutische zusammensetzungen daraus.
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
FI891570A (fi) Menetelmä piroksikaamia sisältävän farmaseuttisen koostumuksen valmistamiseksi
DK561089D0 (da) Anvendelse af lactamimider til fremstilling af laegemidler
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
DK0443848T3 (da) Nyt antiulcermiddel
NZ231320A (en) Aqueous oral preparations of diclofenac
DE69010523D1 (de) Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
NO901231L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO893256D0 (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
NO883986L (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
EP0149475A3 (en) Medicaments for the treatment and prevention of liver damage
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
ATE64855T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments
ATE100318T1 (de) Verwendung von chinolyl- und isochinolyloxazol-2- onen zur herstellung eines arzneimittels zur verhinderung der ansteckungsfaehigkeit von mit glykoproteinen umhuellten viren.
DE69409633T2 (de) Transdermal behandlung von krebs mit wasserunlöslichem s-camtothecin mit geschlossenem lactoring
NO903705D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n-disubstituerte arylcykloalkylaminer.
IT8723007A0 (it) Composizioni farmaceutiche per uso orale ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo, e procedimento per prepararle